rs1545119
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000137.4(FAH):c.553+33A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.728 in 1,610,242 control chromosomes in the GnomAD database, including 428,100 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.73 ( 40974 hom., cov: 29)
Exomes 𝑓: 0.73 ( 387126 hom. )
Consequence
FAH
NM_000137.4 intron
NM_000137.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.209
Publications
15 publications found
Genes affected
FAH (HGNC:3579): (fumarylacetoacetate hydrolase) Predicted to enable fumarylacetoacetase activity. Predicted to be involved in L-phenylalanine catabolic process; homogentisate catabolic process; and tyrosine catabolic process. Predicted to act upstream of or within arginine catabolic process. Located in extracellular exosome. Implicated in tyrosinemia type I. [provided by Alliance of Genome Resources, Apr 2022]
FAH Gene-Disease associations (from GenCC):
- tyrosinemia type IInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine, G2P, Orphanet, Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 15-80168182-A-G is Benign according to our data. Variant chr15-80168182-A-G is described in ClinVar as Benign. ClinVar VariationId is 255282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.854 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FAH | NM_000137.4 | c.553+33A>G | intron_variant | Intron 6 of 13 | ENST00000561421.6 | NP_000128.1 | ||
| FAH | NM_001374377.1 | c.553+33A>G | intron_variant | Intron 7 of 14 | NP_001361306.1 | |||
| FAH | NM_001374380.1 | c.553+33A>G | intron_variant | Intron 7 of 14 | NP_001361309.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FAH | ENST00000561421.6 | c.553+33A>G | intron_variant | Intron 6 of 13 | 1 | NM_000137.4 | ENSP00000453347.2 |
Frequencies
GnomAD3 genomes AF: 0.734 AC: 111294AN: 151576Hom.: 40947 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
111294
AN:
151576
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.731 AC: 183153AN: 250622 AF XY: 0.738 show subpopulations
GnomAD2 exomes
AF:
AC:
183153
AN:
250622
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.727 AC: 1060366AN: 1458552Hom.: 387126 Cov.: 33 AF XY: 0.730 AC XY: 530235AN XY: 725878 show subpopulations
GnomAD4 exome
AF:
AC:
1060366
AN:
1458552
Hom.:
Cov.:
33
AF XY:
AC XY:
530235
AN XY:
725878
show subpopulations
African (AFR)
AF:
AC:
25469
AN:
33438
American (AMR)
AF:
AC:
27634
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
18764
AN:
26106
East Asian (EAS)
AF:
AC:
35102
AN:
39688
South Asian (SAS)
AF:
AC:
72507
AN:
86202
European-Finnish (FIN)
AF:
AC:
35946
AN:
52734
Middle Eastern (MID)
AF:
AC:
4541
AN:
5754
European-Non Finnish (NFE)
AF:
AC:
796043
AN:
1109630
Other (OTH)
AF:
AC:
44360
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
16399
32799
49198
65598
81997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19924
39848
59772
79696
99620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.734 AC: 111373AN: 151690Hom.: 40974 Cov.: 29 AF XY: 0.734 AC XY: 54342AN XY: 74066 show subpopulations
GnomAD4 genome
AF:
AC:
111373
AN:
151690
Hom.:
Cov.:
29
AF XY:
AC XY:
54342
AN XY:
74066
show subpopulations
African (AFR)
AF:
AC:
31714
AN:
41354
American (AMR)
AF:
AC:
10149
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
2476
AN:
3462
East Asian (EAS)
AF:
AC:
4495
AN:
5134
South Asian (SAS)
AF:
AC:
3966
AN:
4804
European-Finnish (FIN)
AF:
AC:
7184
AN:
10480
Middle Eastern (MID)
AF:
AC:
227
AN:
288
European-Non Finnish (NFE)
AF:
AC:
48884
AN:
67908
Other (OTH)
AF:
AC:
1577
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1507
3013
4520
6026
7533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2836
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Tyrosinemia type I Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 26, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.